TW200626127A - Dried material and method for producing the same - Google Patents

Dried material and method for producing the same

Info

Publication number
TW200626127A
TW200626127A TW094141677A TW94141677A TW200626127A TW 200626127 A TW200626127 A TW 200626127A TW 094141677 A TW094141677 A TW 094141677A TW 94141677 A TW94141677 A TW 94141677A TW 200626127 A TW200626127 A TW 200626127A
Authority
TW
Taiwan
Prior art keywords
dried material
extract
producing
same
production
Prior art date
Application number
TW094141677A
Other languages
Chinese (zh)
Other versions
TWI440454B (en
Inventor
Masaharu Kurohashi
Yoji Shibayama
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2005132070A external-priority patent/JP3818657B2/en
Priority claimed from JP2005298472A external-priority patent/JP4024810B2/en
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Publication of TW200626127A publication Critical patent/TW200626127A/en
Application granted granted Critical
Publication of TWI440454B publication Critical patent/TWI440454B/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention is aimed to provide a dried material of an extract of the inflammatory skin of rabbits inoculated with viral vaccine, which has inhibitory effect on kallikrein production, and a method for producing the same. In order to produce an oral solid preparation containing an extract of the inflammatory skin of rabbits inoculated with viral vaccine as the active ingredient, the present invention provides a method for producing a dried material of said extract, comprising, during drying, adding sugar, sugar alcohol or ascorbic acid to the extract before the extract is completely dried. By this method, a dried material having inhibitory effect on kallikrein production can be obtained, and said dried material can be used in production of an oral solid preparation such as a tablet.
TW94141677A 2004-12-01 2005-11-28 Dried material and method for producing the same TWI440454B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2004348904 2004-12-01
JP2005132070A JP3818657B2 (en) 2004-12-01 2005-04-28 Dried product and production method thereof
JP2005177334 2005-06-17
JP2005298472A JP4024810B2 (en) 2005-06-17 2005-10-13 Dried product and production method thereof

Publications (2)

Publication Number Publication Date
TW200626127A true TW200626127A (en) 2006-08-01
TWI440454B TWI440454B (en) 2014-06-11

Family

ID=51393002

Family Applications (1)

Application Number Title Priority Date Filing Date
TW94141677A TWI440454B (en) 2004-12-01 2005-11-28 Dried material and method for producing the same

Country Status (1)

Country Link
TW (1) TWI440454B (en)

Also Published As

Publication number Publication date
TWI440454B (en) 2014-06-11

Similar Documents

Publication Publication Date Title
WO2007120811A3 (en) Hemangio-colony forming cells
WO2010037066A3 (en) Dosage units of 3-(6-(1-(2,2-difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
PH12015500633A1 (en) Method for preparing imp fermented broth or glutamic acid fermented broth as raw material for preparation of natural flavor
WO2006024490A3 (en) Methods and compositions for the treatment of cell proliferation
WO2006072347A3 (en) Alkinyl-substituted thiophenes
UA92861C2 (en) Pharmaceutical composition for treating depression and process for the preparation thereof
UA105487C2 (en) Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
WO2008013966A3 (en) Use of 8-quinolinol and its analogs to target cancer stem cells
NO20080554L (en) pyrazolone
MX2010001849A (en) Cyclic depsipeptides.
IL177658A0 (en) Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
WO2009004629A3 (en) A method for decreasing symptoms of alcohol consumption
WO2008070859A3 (en) Treatment of skin conditions by dickkopf1 (dkk1)
NZ600695A (en) Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency
WO2011037976A3 (en) Pramipexole pharmaceutical formulations
TW200745132A (en) Novel, acyclically substituted furopyrimidine derivatives and use thereof
ATE459363T1 (en) DRIED EXTRACT FROM INFLAMED RABBIT SKIN VACCINATED WITH VACCINIA VIRUSES AND PROCESS FOR PRODUCTION
EP3111924A3 (en) Oral care compositions
MX2019000031A (en) Methods for the preparation of a levothyroxine solution.
DE502005005652D1 (en) Heterocyclic sub-substituted nononepipepidites
ATE455789T1 (en) SUBSTITUTED NONADEPSIPEPTIDES
WO2011056775A3 (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
WO2009084036A3 (en) Composition for treatment of viral infections
ATE488226T1 (en) MAHONIA AQUIFOLIUM EXTRACT, EXTRACTION METHOD AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
ATE529121T1 (en) HERBAL COMPOSITION